Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |